BOTT yields 0.13% · JNJ yields 2.14%● Live data
📍 JNJ pulled ahead of the other in Year 5
Combined, BOTT + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of BOTT + JNJ for your $10,000?
BOTT aims to track a narrow index of global companies specializing in humanoid robotics. The index includes companies involved in service, industrial, autonomous, assistive/wearable robots, and enabling AI/hardware. The index provider uses a proprietary AI (ARTIS) to score the eligible universe, selecting the top 30 companies based on their revenue exposure to humanoid robotics. The selection process is conducted 20 business days prior to each quarterly rebalance, which is held on the first Wednesday of February, May, August, and November. Holdings are weighted based on revenue exposure, with a cap of 4.5%. Sector weights may shift, and the fund does not take defensive positions. It can invest in China A, B, H, N, P, and S shares, but excludes sanctioned securities. Prior to August 18, 2025, the fund tracked the Solactive Industrial Robotics & Automation Index.
Full BOTT Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.